Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 246

Results For "API"

3145 News Found

Qure.ai raises US $ 40 million from healthcare investors Novo Holdings and HealthQuad
Digitisation | March 29, 2022

Qure.ai raises US $ 40 million from healthcare investors Novo Holdings and HealthQuad

The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development


Philips expands network of clinical partners for early diagnosis and treatment of lung cancer
Medical Device | March 28, 2022

Philips expands network of clinical partners for early diagnosis and treatment of lung cancer

Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases


New spesolimab data show promising results in patients with generalised pustular psoriasis flares
Biotech | March 28, 2022

New spesolimab data show promising results in patients with generalised pustular psoriasis flares

Clinical improvements were consistent across patient subgroups including age, gender, ethnicity, and IL-36 gene mutation status


ILC Dover launches liquid single-use bioprocessing bags for biotherapeutics market
Biotech | March 28, 2022

ILC Dover launches liquid single-use bioprocessing bags for biotherapeutics market

The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain


Confluent Medical Technologies to set up facility in Hyderabad
News | March 26, 2022

Confluent Medical Technologies to set up facility in Hyderabad

Arizona-based, leading medical devices company, Confluent Medical Technologies, will be establishing a pilot manufacturing facility in Hyderabad.


Aquavit Files IND with USFDA for DTX-021, a new botulinum toxin
Drug Approval | March 25, 2022

Aquavit Files IND with USFDA for DTX-021, a new botulinum toxin

Aquavit will officially unveil the Dermatox and Microtox programs at the Annual American Academy of Dermatology, the world's largest dermatology conference scheduled from March 25-29, 2022, in Boston, MA


USFDA approves Janssen’s injectable regimen for HIV
Drug Approval | March 25, 2022

USFDA approves Janssen’s injectable regimen for HIV

Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV


Medtronic announces first patient implants for bladder incontinence
Medical Device | March 25, 2022

Medtronic announces first patient implants for bladder incontinence

Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy


CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma
News | March 25, 2022

CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma

Recommendation is based on pivotal data from the phase III POLARIX study


SRL Diagnostics launches whole genome sequencing test for Tuberculosis
Clinical Trials | March 24, 2022

SRL Diagnostics launches whole genome sequencing test for Tuberculosis

The test can overcome the time and cost limitations of traditional culture-based drug susceptibility testing as it can more rapidly detect all mutations known to be associated with drug resistance for any TB drug in one step